Pepgen Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.85

+0.06 (+3.35%)

As of May 9, 1:55 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 1 8%

Sell 1 8%

Price Target

Analyst Price Target +2,006.5% upside

Low Target $29.17

Average Target $38.97

High Target $44.78

Current Price $1.85

Current
$1.85

Target
$38.97

$29.17 $38.97 avg $44.78

Scenario Analysis

Bear Case

$29.17

1,476.8%

Low target

Base Case

$38.97

+2,006.5%

Avg target

Bull Case

$44.78

+2,320.5%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$7.80

-76.3% from high

52-Week Low

$1.01

+83.2% from low

Target vs 52W High

$38.97

+399.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%